华大智造：上半年亏损1.04亿元 同比减亏

Core Viewpoint - The company BGI Genomics (688114) reported a decline in revenue and a reduced net loss for the first half of 2025 compared to the previous year [1] Financial Performance - The company achieved operating revenue of 1.114 billion yuan in the first half of 2025, representing a year-on-year decrease of 7.9% [1] - The net profit attributable to the parent company was a loss of 104 million yuan, an improvement from a loss of 298 million yuan in the same period last year, indicating a reduction in losses [1] - The primary reason for the reduced net loss was the company's ongoing cost reduction and efficiency improvement efforts, which led to a decrease in expenses [1]